CLPT Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Clearpoint Neuro Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 5.87 USD 6.34%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast CLPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLPT is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

CLPT Lowest Forecast

Wall Street Target

CLPT Average Forecast

Wall Street Target

CLPT Highest Forecast

Wall Street Target

55% Upside

74% Upside

97% Upside

The latest public price target was made on Mar 13, 2024 by Mathew Blackman from Stifel Nicolaus , who expects CLPT stock to rise by 53% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Mathew Blackman Stifel Nicolaus	9 USD Upside 53%	1 month ago Mar 13, 2024	Clearpoint Neuro Inc. (CLPT) PT Raised to $9 at Stifel StreetInsider

Price Target	9 USD
Upside/Downside	53%

Beijing Bohui Innovation Biotechnology Group Co Ltd

58% Upside

Dentium Co Ltd

33% Upside

Vieworks Co Ltd

42% Upside

ImpediMed Ltd

123% Upside

Beijing Bohui Innovation Biotechnology Group Co Ltd

58% Upside

Dentium Co Ltd

33% Upside

Vieworks Co Ltd

42% Upside

ImpediMed Ltd

123% Upside

Biocorp Production SA

1% Upside

Shenzhen Mindray Bio-Medical Electronics Co Ltd

31% Upside

Semler Scientific Inc

146% Upside

Envista Holdings Corp

21% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Clearpoint Neuro Inc's revenue is 23%. The projected CAGR for the next 3 years is 35%.

23%

35%

-2%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-4%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-23%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for CLPT is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

For the last 8 years the compound annual growth rate for Clearpoint Neuro Inc's revenue is 23%. The projected CAGR for the next 3 years is 35%.

Join more than 134,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.